课题基金 / 基金详情

SUPPORT FOR THE CONDUCT OF STUDIES TO EVALUATE THE TOXICOLOGIC POTENTIAL OF Garcinia cambogia FOR THE NTP

SUPPORT FOR THE CONDUCT OF STUDIES TO EVALUATE THE TOXICOLOGIC POTENTIAL OF Garcinia cambogia FOR THE NTP
支持开展研究以评估藤黄果对 NTP 的毒理学潜力
批准号:
10026338
负责人:
BARNEY SPARROW
金额:
$166.49万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-26 至 2019-09-25

项目摘要

项目成果

BARNEY SPARROW的其他基金

相关文献

中文摘要
翻译
藤黄果提取物(GCE)被提名为测试的基础上,其广泛使用的饮食援助和缺乏足够的毒性数据。它是2016年美国第六畅销的膳食补充剂(Smith等人,2017年)。GCE是从Garcinia gummi-gutta(从Garcinia cambogia重新命名)水果的果皮制备的,含有GCE的产品作为无麻黄的饮食辅助剂销售。GCE的预期作用包括抑制食欲、抑制脂质合成和通过产热燃烧脂肪。通常,GCE作为减肥补充剂的使用是通过每天三次饭前服用的囊片,导致总剂量约为4,500 - 6,000 mg/天(对于60 kg的人,约为75-100 mg/kg/天)。由于推荐的GCE方案(每日3次,与食物一起)以及传统上使用藤黄属作为印度美食中的成分,因此选择给药饲料作为给药途径,而不是口服灌胃,口服灌胃通常与草药供试品一起使用,并提供每日推注剂量。
英文摘要
Garcinia cambogia extract (GCE) was nominated for testing based on its widespread use as a diet aid and a lack of adequate toxicity data. It was the 6th best-selling dietary supplement in the U.S. in 2016 (Smith et al., 2017). GCE is prepared from the rind of Garcinia gummi-gutta (renamed from Garcinia cambogia) fruit and products containing GCE are marketed as ephedra-free diet aids. Purported effects of GCE include appetite suppression, inhibition of lipid synthesis, and fat burning via thermogenesis. Typically, the use of GCE as a weight loss supplement is via caplets taken prior to meals three times per day, resulting in a total dose of approximately 4,500-6,000 mg/day (~75-100 mg/kg/day for a 60 kg person). Due to the recommended regimen of GCE (3 times daily with food) as well as the traditional use of Garcinia as an ingredient in Indian cuisine, dosed-feed was selected as the route of administration, as opposed to oral gavage, which has typically been employed with herbal test articles and delivers a daily bolus dose.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Production of TempOSeq data for the DrugMatrix reference library
  • 批准号:
    10710454
  • 项目类别:
  • 资助金额:
    $110.04万
  • 财政年份:
    2017
  • 负责人:
    BARNEY SPARROW
  • 依托单位:
Systematic Evaluation of the Application of Zebrafish in Toxicology (SEAZIT) Phase 2
  • 批准号:
    10213572
  • 项目类别:
  • 资助金额:
    $100.0万
  • 财政年份:
    2017
  • 负责人:
    BARNEY SPARROW
  • 依托单位:
Evaluation of HepaRG cells as a screen for chemical toxicity and assay optimization
  • 批准号:
    10700772
  • 项目类别:
  • 资助金额:
    $3.76万
  • 财政年份:
    2017
  • 负责人:
    BARNEY SPARROW
  • 依托单位: